Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Moderna and Merck Unveil Cancer Vaccine Breakthrough After Century-Long Quest

Guavy AI Editorial Team
Instruments
MRK
Share

Moderna and Merck's cancer vaccine breakthrough has been hailed as a success after years of research. According to Reuters, Moderna CEO Stephane Bancel received a call while celebrating a friend's birthday on August 13th, informing him of the breakthrough.

The vaccine was developed through a collaboration between Moderna and Merck, with the goal of treating various types of cancer. This achievement marks a significant milestone in the fight against cancer, which has been a major challenge for researchers and healthcare professionals for over a century.

More on Stocks

Stocks 6m ago

US Open Treats American Express Platinum Card Members with Luxury Gift Bags

Stocks 6m ago

US Open Fans Get Customizable Phone Charms courtesy of American Express

Stocks 6m ago

US Open Fans Get Customizable Phone Charms at Amex Fan Experience

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy